Riding the Tide, Pioneering the Future | Shenzhen Cell Valley Holds 2024 Mid-Year All-Staff Meeting

August is a season of harvest and hope. On the morning of August 6, Shenzhen Cell Valley held an all-staff meeting themed "Riding the Tide, Pioneering the Future." Chairman Shi Yuanyuan, Chief Scientist Wang Jianxun, Deputy General Manager Tang Xiaomeng, along with all employees from the Shenzhen headquarters and wholly-owned subsidiaries Junhou Bio and Jing-Shen Cell Valley, attended the meeting both online and offline. The meeting aimed to review the diligent efforts and outstanding achievements of the first half of the year, while also looking ahead to jointly chart a new blueprint for the cell therapy field.

During the meeting, Chairman Shi Yuanyuan provided a comprehensive and in-depth overview of the company from multiple dimensions, including strategic development progress, corporate growth and major breakthroughs, the current economic climate, and work plans and core tasks for the second half of the year.

Corporate Strategic Development Progress

In his opening address, Chairman Shi Yuanyuan first provided a comprehensive review of the company's development journey. He noted that Shenzhen Cell Valley has firmly established its industry position in the domestic market and, through strategic planning carefully devised by the Board of Directors, has achieved steady growth. In its internationalization process, Shenzhen Cell Valley established a wholly-owned subsidiary in Hong Kong—a significant move that has laid a solid foundation for the company's expansion into Southeast Asian and North American markets, effectively advancing the pace of its global development.

Corporate Growth and Major Breakthroughs

Subsequently, Chairman Shi presented, through rigorous data and charts, the company's significant achievements and major breakthroughs across multiple areas of corporate development.

Internship retention rate reached 75%, reflecting the effectiveness of the company's talent strategy.

Timely adjustments to the organizational structure have provided strong support for the company's efficient operations.

Appointment of an internationally renowned medical doctor as Chief Medical Advisor, further enhancing the company's professional caliber and international influence.

Notably, Shenzhen Cell Valley's product pipeline is showing robust growth, with an increasingly rich and comprehensive product line. In the realm of independent R&D projects, the company has achieved remarkable breakthroughs: successfully innovating Human NK cell cryopreservation technology, actively advancing the development of Mouse NK cells, and establishing the eVLP delivery platform. Significant progress has also been made in the optimization of γδT cells and BaEV transduction. These achievements have laid a solid foundation for the company's leading position in the cell therapy field. Through relentless innovation, Shenzhen Cell Valley's R&D technology team has successfully pioneered a new landscape for off-the-shelf cell products, injecting new vitality into the company's development. In CRO projects, the company has collaborated with multiple domestic public tertiary hospitals, achieving important breakthroughs in several projects, marking widespread industry recognition of the company's professional capabilities and service quality in the CRO field.

The Current Economic Climate

Chairman Shi Yuanyuan clearly stated that the biopharmaceutical industry faces multiple severe challenges, including significant technological barriers, long return cycles, and extreme difficulty in manufacturing quality control. Given the current severe economic environment, with broad-based asset depreciation and severely impacted market confidence, Shenzhen Cell Valley, as a technology-driven enterprise, has demonstrated unique resilience and determination. The company closely tracks the latest developments in the international biopharmaceutical field, riding the tide and firmly advancing toward its goal of becoming one of China's leading CGT companies.

Work Plans and Core Tasks for the Second Half of the Year

Chairman Shi Yuanyuan clearly outlined four major requirements for the goals and work priorities of the second half of the year, ensuring the smooth progression of the company's overall strategy and the successful achievement of annual targets. First, at the goal-oriented level, the Chairman emphasized that all employees must maintain firm conviction, closely focus on annual targets, and concentrate their attention on core tasks. Every employee must possess an unwavering determination to win, courageously face challenges, and ensure the smooth attainment of goals. Second, in terms of strategic planning, the Chairman pointed out that continued efforts are needed in key areas such as project initiation, recognition acquisition, and international cooperation. At the same time, adequate attention must be given to international market development to drive the deep implementation of the company's globalization strategy. Third, at the internal management level, the Chairman required department heads to clearly structure their work plans, ensuring all activities are aligned with established objectives. The company will next establish and improve a performance uation mechanism with clear rewards and penalties, effective incentives, and maximized value realization for every employee. Finally, in terms of business operations, the Chairman emphasized that all project initiation and resource allocation must be closely centered on market demand. The company should continuously monitor market dynamics and adjust business strategies in a timely manner to ensure that resources are directed toward highefficiency areas, maximizing the company's economic returns.

In the second half of 2024, under the leadership of Chairman Shi Yuanyuan, Shenzhen Cell Valley will closely focus on core work tasks and spare no effort in advancing all operations in an orderly manner. In this industry context where challenges and opportunities coexist: "Blossom in the winter, rise in adversity!" We firmly believe that only through the trials of harsh winter can one bloom with even greater brilliance; only through perseverance in adversity can one achieve a more splendid rise. Shenzhen Cell Valley will join hands with all employees to write a brilliant chapter that belongs to us!